Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
203 USD | +0.14% | -3.42% | -19.30% |
Apr. 17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare |
Financials (USD)
Sales 2024 * | 1.25B | Sales 2025 * | 1.45B | Capitalization | 7.86B |
---|---|---|---|---|---|
Net income 2024 * | 106M | Net income 2025 * | 154M | EV / Sales 2024 * | 6.13 x |
Net cash position 2024 * | 217M | Net cash position 2025 * | 353M | EV / Sales 2025 * | 5.18 x |
P/E ratio 2024 * |
73.6
x | P/E ratio 2025 * |
52.1
x | Employees | 4,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.18% |
Latest transcript on Penumbra, Inc.
1 day | +0.14% | ||
1 week | -3.42% | ||
Current month | -9.04% | ||
1 month | -9.67% | ||
3 months | -19.68% | ||
6 months | -1.22% | ||
Current year | -19.30% |
Managers | Title | Age | Since |
---|---|---|---|
Arani Bose
FOU | Founder | 62 | 04-06-20 |
Adam Elsesser
CEO | Chief Executive Officer | 62 | 04-06-20 |
Maggie Yuen
DFI | Director of Finance/CFO | 52 | 19-12-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Wilder
BRD | Director/Board Member | 60 | 17-01-12 |
Harpreet Grewal
BRD | Director/Board Member | 57 | 15-03-31 |
Adam Elsesser
CEO | Chief Executive Officer | 62 | 04-06-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.21% | 16 M€ | -7.93% | ||
1.18% | 2 M€ | -1.17% | - | |
0.33% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 203 | +0.14% | 348,377 |
24-04-19 | 202.7 | +0.44% | 338,662 |
24-04-18 | 201.8 | -3.28% | 330,454 |
24-04-17 | 208.7 | -0.65% | 346,505 |
24-04-16 | 210 | -0.07% | 232,495 |
Delayed Quote Nyse, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.30% | 7.86B | |
+72.44% | 12.33B | |
+3.88% | 5.77B | |
+7.87% | 5.1B | |
+20.28% | 4.29B | |
-20.59% | 3.92B | |
-41.57% | 2.2B | |
-3.22% | 1.92B | |
-1.66% | 1.76B | |
-20.76% | 1.27B |
- Stock Market
- Equities
- PEN Stock